Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database

Christine SM Lau1 Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA;2 Saint George’s University School of Medicine, Grenada, West Indies

Krishnaraj Mahendraraj1 Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA

Ronald S Chamberlain1 Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA;2 Saint George’s University School of Medicine, Grenada, West Indies;3 Department of Surgery, New Jersey Medical School, Rutgers University, Newark, NJ;4 Department of Surgery, Banner MD Anderson Cancer Center, Gilbert, AZ, USACorrespondence[email protected]

Pages 159-166 | Published online: 02 May 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AhmedROborskiMJHwangMLiebermanFSMountzJMMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsCancer Manag Res2014614917024711712
PubMed Web of Science ®Google Scholar
KoellerKKRushingEJFrom the archives of the AFIP: oligodendroglioma and its variants: radiologic-pathologic correlationRadiograph-ics200525616691688
Web of Science ®Google Scholar
LeeYYVanTPIntracranial oligodendrogliomas: imaging findings in 35 untreated casesAJR Am J Roentgenol198915223613692783515
PubMed Web of Science ®Google Scholar
CreachKMRubinJBLeonardJROligodendrogliomas in childrenJ Neurooncol2012106237738221842314
PubMed Web of Science ®Google Scholar
NielsenMSChristensenHCKosteljanetzMJohansenCIncidence of and survival from oligodendroglioma in Denmark, 1943-2002Neuro Oncol200911331131719066344
PubMed Web of Science ®Google Scholar
EngelhardHHSteleaACochranEJOligodendroglioma: pathology and molecular biologySurg Neurol200258211111712453646
PubMedGoogle Scholar
YuTKangHCLimDHPattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12J Neurooncol2015121353153925391968
PubMed Web of Science ®Google Scholar
FleuryAMenegozFGrosclaudePDescriptive epidemiology of cerebral gliomas in FranceCancer1997796119512029070498
PubMed Web of Science ®Google Scholar
ShawEGScheithauerBWO’FallonJRTazelaarHDDavisDHOligodendrogliomas: the Mayo Clinic experienceJ Neurosurg19927634284341738022
PubMed Web of Science ®Google Scholar
SnyderLAWolfABOppenlanderMEThe impact of extent of resection on malignant transformation of pure oligodendrogliomasJ Neurosurg2014120230931424313617
PubMed Web of Science ®Google Scholar
RusthovenCGCarlsonJAWaxweilerTVThe impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States populationInt J Radiat Oncol Biol Phys201490489490225585784
PubMed Web of Science ®Google Scholar
van den BentMJAfraDdeWOLong-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trialLancet2005366949098599016168780
PubMed Web of Science ®Google Scholar
CairncrossJGMacdonaldDRSuccessful chemotherapy for recurrent malignant oligodendrogliomaAnn Neurol19882343603643382171
PubMed Web of Science ®Google Scholar
CairncrossGMacdonaldDLudwinSChemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials GroupJ Clin Oncol19941210201320217931469
PubMed Web of Science ®Google Scholar
WickWHartmannCEngelCNOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideJ Clin Oncol200927355874588019901110
PubMed Web of Science ®Google Scholar
CairncrossGBerkeyBShawEPhase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402J Clin Oncol200624182707271416782910
PubMed Web of Science ®Google Scholar
van den BentMJCarpentierAFBrandesAAAdjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trialJ Clin Oncol200624182715272216782911
PubMed Web of Science ®Google Scholar
van den BentMJBrandesAATaphoornMJAdjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951J Clin Oncol201331334435023071237
PubMed Web of Science ®Google Scholar
JastaniyahNMurthaAPervezNPhase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiformeRadiat Oncol201383823425509
PubMed Web of Science ®Google Scholar
SpeirsCKSimpsonJRRobinsonCGImpact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomideInt J Radiat Oncol Biol Phys201591226827625636755
PubMed Web of Science ®Google Scholar
ChamberlainMCJohnstonSBevacizumab for recurrent alkylator-refractory anaplastic oligodendrogliomaCancer200911581734174319197992
PubMed Web of Science ®Google Scholar
SandmannTBourgonRGarciaJPatients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trialJ Clin Oncol201533252735274426124478
PubMed Web of Science ®Google Scholar
ChinotOLde La MotteRTMooreNAVAglio: phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiformeAdv Ther201128433434021432029
PubMed Web of Science ®Google Scholar
GilbertMRDignamJJArmstrongTSA randomized trial of bevacizumab for newly diagnosed glioblastomaN Engl J Med2014370869970824552317
PubMed Web of Science ®Google Scholar
FavaroRAppolloniIPellegattaSSox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendrogliomaCancer Res20147461833184424599129
PubMed Web of Science ®Google Scholar
ChenJRYaoYXuHZQinZYIsocitrate dehydrogenase (IDH)1/2 mutations as prognostic markers in patients with glioblastomasMedicine (Baltimore)2016959e258326945349
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date